Compound ID | 3522

Update compound information

AD101

Synonym(s): AD-101  |  AD 101

Agent Type: Direct acting;
Spectrum of activity: Gram-positive, Gram-negative & Antimycobacterial
Mechanism of action: Protein synthesis inhibitor
Target Pathogen: Active against Staphylococcus aureus, Enterococcus faecium, Pseudomonas aeruginosa, Enterobacterales, and Mycobacterium tuberculosis
Institute where first reported: UPOL/IMTM
Highest development stage: Preclinical
Development status: Experimental
External links:
Citation: https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/who-antibacterial-preclinical-pipeline-review

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.